Hopman Mark sold BBNX
October 26, 2026 · Form 4 insider transaction
Hopman Mark sold 821 shares of Beta Bionics, Inc. at $20.00 per share, a transaction worth $16.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
821
Price
$20.00
Total value
$16.4K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after54,513
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.